文献速递呼吸道感染呼吸危重症与机械通气

高分子量透明质酸在离体灌注人肺细菌性肺炎中的治疗作用

Therapeutic Effects of Hyaluronic Acid in Bacterial Pneumonia in Ex Vivo Perfused Human Lungs.
PubMed 文献 · Am J Respir Crit Care Med · 2019-01-01

本研究利用离体灌注人肺模型,探讨严重大肠杆菌肺炎释放的细胞外囊泡(EVs)在急性肺损伤(ALI)中的作用,并评估高分子量透明质酸(HMW HA)的治疗效果。结果显示,HMW HA可减轻EVs或细菌肺炎导致的肺泡液体清除障碍、蛋白通透性增加和急性炎症,并减少大肠杆菌肺炎后的总细菌计数。机制上,HMW HA与EVs结合,抑制单核细胞对EVs的摄取及TNFα分泌,同时增加对大肠杆菌的吞噬作用。

要点

  • HMW HA减轻大肠杆菌EVs或肺炎诱导的肺损伤和炎症。
  • HMW HA结合EVs,抑制单核细胞摄取EVs及TNFα分泌。
  • HMW HA增加单核细胞对大肠杆菌的吞噬,降低细菌计数。

核心结论

  • 严重细菌性肺炎释放的EVs具有促炎性并诱导急性肺损伤。
  • HMW HA能抑制靶细胞对EVs的摄取,减轻EVs或细菌性肺炎所致的肺损伤。

研究设计与样本

  • 离体灌注人肺模型:大肠杆菌肺炎6小时后超速离心收集EVs,经支气管或静脉给予 naive 肺,1小时后灌注HMW HA(n=5-6)。
  • 单独实验:大肠杆菌肺炎后给予HMW HA(n=6-10)。
  • 体外实验评估EVs与HMW HA结合及人单核细胞对EVs的摄取。

主要发现

  • HMW HA改善大肠杆菌EVs或肺炎导致的肺泡液体清除障碍、蛋白通透性增加和急性炎症。
  • HMW HA减少大肠杆菌肺炎后的总细菌计数。
  • HMW HA与大肠杆菌EVs结合,抑制人单核细胞对EVs的摄取,并减少TNFα分泌。
  • HMW HA增加单核细胞对大肠杆菌的吞噬作用。

临床怎么用

  • HMW HA可能作为细菌性肺炎急性肺损伤的潜在治疗策略,但需进一步临床验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: Recent studies have demonstrated that extracellular vesicles (EVs) released during acute lung injury (ALI) were inflammatory.Objectives: The current study was undertaken to test the role of EVs induced and released from severe Escherichia coli pneumonia (E. coli EVs) in the pathogenesis of ALI and to determine whether high-molecular-weight (HMW) hyaluronic acid (HA) administration would suppress lung injury from E. coli EVs or bacterial pneumonia.Methods:E. coli EVs were collected from the perfusate of an ex vivo perfused human lung injured with intrabronchial E. coli bacteria for 6 hours by ultracentrifugation and then given intrabronchially or intravenously to naive human lungs. One hour later, HMW HA was instilled into the perfusate (n = 5-6). In separate experiments, HMW HA was given after E. coli bacterial pneumonia (n = 6-10). In vitro experiments were conducted to evaluate binding of EVs to HMW HA and uptake of EVs by human monocytes.Measurements and Main Results: Administration of HMW HA ameliorated the impairment of alveolar fluid clearance, protein permeability, and acute inflammation from E. coli EVs or pneumonia and reduced total bacteria counts after E. coli pneumonia. HMW HA bound to E. coli EVs, inhibiting the uptake of EVs by human monocytes, an effect associated with reduced TNFα (tumor necrosis factor α) secretion. Surprisingly, HMW HA increased E. coli bacteria phagocytosis by monocytes.Conclusions: EVs induced and released during severe bacterial pneumonia were inflammatory and induced ALI, and HMW HA administration was effective in inhibiting the uptake of EVs by target cells and decreasing lung injury from E. coli EVs or bacterial pneumonia.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Liu A, Park JH, Zhang X, et al. Therapeutic Effects of Hyaluronic Acid in Bacterial Pneumonia in Ex Vivo Perfused Human Lungs. Am J Respir Crit Care Med. 2019. PMID: 31390880. doi:10.1164/rccm.201812-2296OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。